Literature DB >> 29797055

ICD lead type and RV lead position in CRT-D recipients.

Alexander P Benz1, Mate Vamos1, Julia W Erath1, Peter Bogyi2, Gabor Z Duray2, Stefan H Hohnloser3.   

Abstract

BACKGROUND: Data on preferred ICD lead type and optimal RV lead position in patients undergoing CRT-D implantation are limited.
OBJECTIVES: To compare dual- versus single-coil ICD leads and non-apical versus apical RV lead position and their impact on clinical parameters and survival in CRT-D recipients.
METHODS: A total of 563 consecutive patients with advanced heart failure and indication for CRT-D implantation were enrolled in two European tertiary centers. Endpoints were improvement in NYHA functional class, changes in echo- and electrocardiographic parameters, and all-cause and cardiovascular mortality.
RESULTS: In this retrospective analysis, a total of 313 (56%) dual- and 250 (44%) single-coil ICD leads were used. RV leads were placed non-apically in 262 (47%) and apically in 296 (53%) patients, respectively. Over a mean follow-up of 41 ± 34 months, all-cause mortality and cardiovascular mortality were similar for patients with dual- versus single-coil ICD lead (adjusted HR 0.81, 95% CI 0.58-1.12 and aHR 1.22, 95% CI 0.73-2.04) and non-apical versus apical RV lead position (aHR 0.98, 95% CI 0.71-1.36 and aHR 0.76, 95% CI 0.44-1.31). Non-apical RV lead position was associated with greater reduction in QRS duration after CRT implantation (- 14.4 ± 32.1 vs. - 4.3 ± 34.3 ms, p < 0.001).
CONCLUSIONS: We found no association between ICD lead type or RV lead position and outcomes in CRT-D recipients. Non-apical RV lead position was associated with larger reduction in QRS duration.

Entities:  

Keywords:  Apical; CRT; Dual coil; Lead position; Septal; Single coil

Mesh:

Year:  2018        PMID: 29797055     DOI: 10.1007/s00392-018-1286-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  36 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  The impact of the right ventricular lead position on response to cardiac resynchronization therapy.

Authors:  Fakhar Z Khan; Pegah Salahshouri; Rudy Duehmke; Philip A Read; Peter J Pugh; Maros Elsik; David Begley; Simon P Fynn; David P Dutka; Munmohan S Virdee
Journal:  Pacing Clin Electrophysiol       Date:  2011-01-05       Impact factor: 1.976

3.  Optimization of right ventricular lead position in cardiac resynchronisation therapy.

Authors:  Lucie Riedlbauchová; Robert Cihák; Jan Bytesník; Vlastimil Vancura; Petr Frídl; Lenka Hosková; Josef Kautzner
Journal:  Eur J Heart Fail       Date:  2006-02-28       Impact factor: 15.534

Review 4.  Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials.

Authors:  Avi Shimony; Mark J Eisenberg; Kristian B Filion; Guy Amit
Journal:  Europace       Date:  2011-07-27       Impact factor: 5.214

5.  Association between right ventricular lead position and clinical outcomes in patients with cardiac resynchronization therapy.

Authors:  Mads Brix Kronborg; Jens Brock Johansen; Sam Riahi; Helen Hoegh Petersen; Jens Haarbo; Ole Dan Jørgensen; Jens Cosedis Nielsen
Journal:  Europace       Date:  2018-04-01       Impact factor: 5.214

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

Authors:  Jeff S Healey; Stefan H Hohnloser; Michael Glikson; Jorg Neuzner; Phillipe Mabo; Xavier Vinolas; Josef Kautzner; Gilles O'Hara; Lieselot VanErven; Fredrik Gadler; Janice Pogue; Ursula Appl; Jim Gilkerson; Thierry Pochet; Kenneth M Stein; Bela Merkely; Susan Chrolavicius; Brandi Meeks; Csaba Foldesi; Bernard Thibault; Stuart J Connolly
Journal:  Lancet       Date:  2015-02-23       Impact factor: 79.321

8.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.

Authors:  Mark A Iler; Tingfei Hu; Sunil Ayyagari; Thomas D Callahan; Kenneth C Civello; Sergio G Thal; Bruce L Wilkoff; Mina K Chung
Journal:  Am J Cardiol       Date:  2007-12-21       Impact factor: 2.778

10.  Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

Authors:  Valentina Kutyifa; Poul Erik Bloch Thomsen; David T Huang; Spencer Rosero; Christine Tompkins; Christian Jons; Scott McNitt; Bronislava Polonsky; Amil Shah; Bela Merkely; Scott D Solomon; Arthur J Moss; Wojciech Zareba; Helmut U Klein
Journal:  Heart Rhythm       Date:  2013-08-22       Impact factor: 6.343

View more
  1 in total

1.  Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices.

Authors:  Sonja Hamed; Bastian Schmack; Florian Mueller; Philipp Ehlermann; Davina Hittmann; Arjang Ruhparwar; Hugo A Katus; Philip W Raake; Michael M Kreusser
Journal:  Clin Res Cardiol       Date:  2019-03-16       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.